203 related articles for article (PubMed ID: 22735964)
1. Characterization of PEGylated biopharmaceutical products by LC/MS and LC/MS/MS.
Huang L; Gough PC
Methods Mol Biol; 2012; 899():351-63. PubMed ID: 22735964
[TBL] [Abstract][Full Text] [Related]
2. Characterization of poly(ethylene glycol) and PEGylated products by LC/MS with postcolumn addition of amines.
Huang L; Gough PC; Defelippis MR
Anal Chem; 2009 Jan; 81(2):567-77. PubMed ID: 19072225
[TBL] [Abstract][Full Text] [Related]
3. Elucidation of PEGylation site with a combined approach of in-source fragmentation and CID MS/MS.
Lu X; Gough PC; DeFelippis MR; Huang L
J Am Soc Mass Spectrom; 2010 May; 21(5):810-8. PubMed ID: 20189826
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of polyethylene glycol (PEG) and PEGylated proteins in animal tissues by LC-MS/MS coupled with in-source CID.
Gong J; Gu X; Achanzar WE; Chadwick KD; Gan J; Brock BJ; Kishnani NS; Humphreys WG; Iyer RA
Anal Chem; 2014 Aug; 86(15):7642-9. PubMed ID: 25003239
[TBL] [Abstract][Full Text] [Related]
5. A strategy for liquid chromatography/tandem mass spectrometry based quantitation of pegylated protein drugs in plasma using plasma protein precipitation with water-miscible organic solvents and subsequent trypsin digestion to generate surrogate peptides for detection.
Wu ST; Ouyang Z; Olah TV; Jemal M
Rapid Commun Mass Spectrom; 2011 Jan; 25(2):281-90. PubMed ID: 21192023
[TBL] [Abstract][Full Text] [Related]
6. Emerging PEGylated drugs.
Kang JS; Deluca PP; Lee KC
Expert Opin Emerg Drugs; 2009 Jun; 14(2):363-80. PubMed ID: 19453284
[TBL] [Abstract][Full Text] [Related]
7. Immunoaffinity purification using anti-PEG antibody followed by two-dimensional liquid chromatography/tandem mass spectrometry for the quantification of a PEGylated therapeutic peptide in human plasma.
Xu Y; Mehl JT; Bakhtiar R; Woolf EJ
Anal Chem; 2010 Aug; 82(16):6877-86. PubMed ID: 20704377
[TBL] [Abstract][Full Text] [Related]
8. Method for characterization of PEGylated bioproducts in biological matrixes.
Liu Q; De Felippis MR; Huang L
Anal Chem; 2013 Oct; 85(20):9630-7. PubMed ID: 24066974
[TBL] [Abstract][Full Text] [Related]
9. Obstacles and pitfalls in the PEGylation of therapeutic proteins.
Gaberc-Porekar V; Zore I; Podobnik B; Menart V
Curr Opin Drug Discov Devel; 2008 Mar; 11(2):242-50. PubMed ID: 18283612
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of therapeutic proteins following direct trypsin digestion of dried blood spot samples and detection by LC-MS-based bioanalytical methods in drug discovery.
Sleczka BG; D'Arienzo CJ; Tymiak AA; Olah TV
Bioanalysis; 2012 Jan; 4(1):29-40. PubMed ID: 22191592
[TBL] [Abstract][Full Text] [Related]
11. Structural characterization of PEGylated rHuG-CSF and location of PEG attachment sites.
Cindrić M; Cepo T; Galić N; Bukvić-Krajacić M; Tomczyk N; Vissers JP; Bindila L; Peter-Katalinić J
J Pharm Biomed Anal; 2007 Jun; 44(2):388-95. PubMed ID: 17448619
[TBL] [Abstract][Full Text] [Related]
12. Gas-phase proton-transfer chemistry coupled with TOF mass spectrometry and ion mobility-MS for the facile analysis of poly(ethylene glycols) and PEGylated polypeptide conjugates.
Bagal D; Zhang H; Schnier PD
Anal Chem; 2008 Apr; 80(7):2408-18. PubMed ID: 18324791
[TBL] [Abstract][Full Text] [Related]
13. PEGylation of therapeutic proteins.
Jevsevar S; Kunstelj M; Porekar VG
Biotechnol J; 2010 Jan; 5(1):113-28. PubMed ID: 20069580
[TBL] [Abstract][Full Text] [Related]
14. Enhanced characterization of complex proteomic samples using LC-MALDI MS/MS: exclusion of redundant peptides from MS/MS analysis in replicate runs.
Chen HS; Rejtar T; Andreev V; Moskovets E; Karger BL
Anal Chem; 2005 Dec; 77(23):7816-25. PubMed ID: 16316193
[TBL] [Abstract][Full Text] [Related]
15. The impact of PEGylation on biological therapies.
Veronese FM; Mero A
BioDrugs; 2008; 22(5):315-29. PubMed ID: 18778113
[TBL] [Abstract][Full Text] [Related]
16. Direct quantitative analysis of a 20 kDa PEGylated human calcitonin gene peptide antagonist in cynomolgus monkey serum using in-source CID and UPLC-MS/MS.
Li H; Rose MJ; Holder JR; Wright M; Miranda LP; James CA
J Am Soc Mass Spectrom; 2011 Sep; 22(9):1660-7. PubMed ID: 21953269
[TBL] [Abstract][Full Text] [Related]
17. Product development issues for PEGylated proteins.
Payne RW; Murphy BM; Manning MC
Pharm Dev Technol; 2011 Oct; 16(5):423-40. PubMed ID: 20858059
[TBL] [Abstract][Full Text] [Related]
18. Pegylated peptides. II. Solid-phase synthesis of amino-, carboxy- and side-chain pegylated peptides.
Lu YA; Felix AM
Int J Pept Protein Res; 1994 Feb; 43(2):127-38. PubMed ID: 8200730
[TBL] [Abstract][Full Text] [Related]
19. Protein carboxyl amidation increases the potential extent of protein polyethylene glycol conjugation.
Li S; Yang Z; Sun X; Tan Y; Yagi S; Hoffman RM
Anal Biochem; 2004 Jul; 330(2):264-71. PubMed ID: 15203332
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of analytical methodologies for the quantification of PCK3145 and PEG-PCK3145 in mice.
Danika C; El Mubarak MA; Leontari I; Sivolapenko GB
Anal Biochem; 2019 Jan; 564-565():72-79. PubMed ID: 30339813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
